Aarti Drugs Ltd PB

PB Ratio of Aarti Drugs Ltd

Image

Aarti Drugs Ltd

NSE: AARTIDRUGS

PB Ratio

2.5

Last updated on: Sep 18, 2026

Key Highlights

  • The latest PB Ratio of Aarti Drugs Ltd is 2.5.
  • The PB ratio of the Aarti Drugs Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors The P/B Ratio of Aarti Drugs Ltd changed from 7.1 on March 2021 to 1.9 on March 2026 . This represents a CAGR of -19.72% over 6 years .

Historical P/B Ratio of Aarti Drugs Ltd

No data available

Company Fundamentals for Aarti Drugs Ltd

Market Cap

3,940 Cr

EPS

21.1

P/E Ratio (TTM)

20.5

P/B Ratio (TTM)

2.5

Day’s High

435.0

Day’s Low

425.15

DTE

0.4

ROE

12.6

52 Week High

534.15

52 Week Low

318.6

ROCE

11.5

Market Price of Aarti Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Aarti Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
18 Sep 2026431.75
17 Sep 2026427.2
16 Sep 2026424
15 Sep 2026426.85
11 Sep 2026428.35
10 Sep 2026436.85
09 Sep 2026424.15
08 Sep 2026421.2
07 Sep 2026423.8
04 Sep 2026431.7

SWOT Analysis Of Aarti Drugs Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Aarti Drugs Ltd

Asset Value vs Market Value of Aarti Drugs Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PB Ratio of Aarti Drugs Ltd Explained

3940

Market cap

170

Book Value per Share

2.5X

PB Ratio

Historical Market Cap of Aarti Drugs Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Aarti Drugs Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Aarti Drugs Ltd News Hub

Aarti Drugs hit 52-week high as board OKs Rs 60-cr share buyback

The buyback price fixed at Rs 900 per equity share, representing a 59.66% premium to Friday's closin

Read more

26 Aug 24

Aarti Drugs to consider buyback

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 26 August 2024. Powered

Read more

22 Aug 24

Aarti Drugs soars on share buyback proposal

The announcement was made after market hours yesterday. Aarti Drugs forms part of $6 Billion Aarti G

Read more

22 Aug 24

Board of Aarti Drugs approves buyback of shares up to Rs 59.85 cr

The Board of Aarti Drugs at its meeting held on 26 August 2024 has approved buyback of up to 6,65,00

Read more

26 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions